Dr. Michelle M. Algarin, MD

Dr. Algarin practices at Laguna Woods Dermatology in Laguna Hills, California.

Dr. Algarin's NPI, 1609872126, was assigned on June 21, 2005. Dr. Algarin graduated from David Geffen School of Medicine at UCLA in 1993. Dr. Algarin holds California license G85189.

Dr. Algarin's primary practice is Laguna Woods Dermatology, at 23961 Calle De La Magdalena Ste 520, Laguna Hills, CA 92653. The practice phone is (949) 855-3376.

Dr. Algarin's primary practice is Laguna Woods Dermatology in Laguna Hills, California. Dmand AI also links Dr. Algarin to 1 physician office, named with a free account. Dr. Algarin's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Algarin practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Algarin's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Algarin is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Algarin's licenses on file in 2 states: California and Texas.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, scalp rash and skin discoloration among the conditions Dr. Algarin treats.

CMS data shows 3,805 Medicare services from Dr. Algarin across 23 procedure codes in 2024, for 683 Medicare patients. Medicare paid $668,749 for them. Every service was in an office.

CMS counts 683 Medicare patients who saw Dr. Algarin in 2024. The largest group is 75 to 84, with 305 patients. 75% of them have high cholesterol, and 70% have high blood pressure. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Algarin's median patient age at 74, with 50% women.

In 2024, Dr. Algarin wrote 395 Medicare Part D claims for 191 patients. 99% of them were for generic drugs. CMS names the drug for 337 of them, across 7 drugs with 11 or more claims each, at $4,747 in total drug cost. In 2023, CMS named 300 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Algarin for performance year 2024, reported individually. Dr. Algarin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Algarin as offering telehealth. CMS counts 942 procedures of removal of skin lesions by Dr. Algarin, more than 93% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 18 general payments to Dr. Algarin from 8 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $260.

Dmand AI lists 2 awards for Dr. Algarin, most recently CMS Stage 1 EHR in 2013.

Dr. Algarin graduated from David Geffen School of Medicine at UCLA in 1993. Dr. Algarin is a member of AAD and American College of Mohs Surgery.

Dr. Algarin is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.